BWH Div of Pharmacoepidemiology and Pharmacoeconomics
Boston, Massachusetts, United States
Joshua J Gagne, PharmD, ScD, FISPE is an Associate Professor of Medicine at Brigham and Womenís Hospital (BWH) and Harvard Medical School and an Associate Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health (Harvard Chan). Josh is the Operations Chief of the US Food and Drug Administrationís (FDAís) new Sentinel Innovation Center. He is also Director of the Pharmacoepidemiology Program at Harvard Chan and Director of the Active Surveillance in Pharmacoepidemiology (ASAP) program at BWH. His research centers on methods for generating comparative safety and effectiveness evidence for drugs and other medical products. Josh teaches courses in pharmacoepidemiology and comparative effectiveness research at Harvard Chan and directs a course through Harvard Catalyst, the Harvard Clinical and Translational Science Center. His research is supported by the FDA, the Patient-Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality, and the Reagan-Udall Foundation. Josh is a recipient of the International Society for Pharmacoeconomics and Outcomes Research Award for Excellence in Application of Pharmacoeconomics and Health Outcomes Research and is a Fellow in the International Society for Pharmacoepidemiology. He serves on the editorial boards of Drug Safety and Pharmacoepidemiology and Drug Safety and is an Associate Editor for PCORI.